Showing results (251-260 of 290) with videos related to
Sort By:
Pageof 29
Nature Communications|March 3, 2025
Systems serology analysis shows IgG1 and IgG3 memory responses six years after one dose of quadrivalent HPV vaccineChau Quang, Jeremy Anderson, Fiona M Russell, et al.The Journal of Allergy and Clinical Immunology|September 1, 2024
Subcutaneous immunotherapy for bee venom allergy induces epitope spreading and immunophenotypic changes in allergen-specific memory B cellsCraig I McKenzie, Simone Reinwald, Brett Averso, et al.Journal of Virology|November 16, 2018
Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected CellsSai Priya Anand, Jérémie Prévost, Sophie Baril, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2017
Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected CohortsVijaya Madhavi, Archana Kulkarni, Ashwini Shete, et al.Cell Reports. Medicine|December 30, 2020
Th2-like T Follicular Helper Cells Promote Functional Antibody Production during <i>Plasmodium falciparum</i> InfectionJo-Anne Chan, Jessica R Loughland, Fabian de Labastida Rivera, et al.Immunity|February 27, 2026
A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malariaD Herbert Opi, Rhea J Longley, Eizo Takashima, et al.Frontiers in Immunology|March 11, 2022
A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After VaccinationMelissa M Lemke, Robert M Theisen, Emily R Bozich, et al.The Journal of Infectious Diseases|July 14, 2026
Afucosylated VAR2CSA-Specific IgG Reduces Risks of Placental MalariaHonghua Ding, Oscar H Lloyd Williams, Maria Saeed, et al.Elife|June 28, 2021
Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malariaElizabeth H Aitken, Timon Damelang, Amaya Ortega-Pajares, et al.Science Translational Medicine|August 11, 2017
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infectionMatthew S Parsons, Sarah B Lloyd, Wen Shi Lee, et al.Pageof 29